NI
FLGT icon

Nepsis Inc’s Fulgent Genetics FLGT Stock Holding History

Nepsis Inc’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-112,306
Closed -$7.01M – 32
2022
Q1 		$7.01M Buy
112,306
+18,430
+20% +$1.21M 2.09% 20
2021
Q4 		$9.44M Sell
93,876
-99,707
-52% -$8.76M 2.74% 20
2021
Q3 		$17.4M Sell
193,583
-10,973
-5% -$997K 5.49% 4
2021
Q2 		$18.9M Buy
204,556
+13,871
+7% +$1.11M 5.98% 4
2021
Q1 		$18.4M Sell
190,685
-60,668
-24% -$6.26M 5.83% 3
2020
Q4 		$13.1M Buy
+251,353
New +$10.5M 4.77% 5

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nepsis Inc's FLGT Position: Q2 2022 in Review

Nepsis Inc sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 112,306 shares — an estimated $7.01M sold.

Nepsis Inc first reported a position in FLGT in Q4 2020 and held it in 6 quarters. The position peaked at $18.9M in Q2 2021. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • Nepsis Inc reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • Nepsis Inc sold 112,306 Fulgent Genetics shares in Q2 2022, an estimated $7.01M.
  • Nepsis Inc first reported a position in Fulgent Genetics in Q4 2020 and held it in 6 quarters.
  • Nepsis Inc's Fulgent Genetics position peaked at $18.9M in Q2 2021.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Nepsis Inc's 13F filing for Q2 2022, filed 2 Aug 2022.